Brief: Paion Approval Of Compassionate Use Program For Remimazolam In Belgium

PAION AG

03/08/2020 14:39

Aug 3 (Reuters) - PAION AG  PA8G.DE :
    * ANNOUNCES APPROVAL OF COMPASSIONATE USE PROGRAM FOR
REMIMAZOLAM
IN BELGIUM
    * REMIMAZOLAM CAN BE USED FOR SEDATION OF INTENSIVE CARE
UNIT
(ICU) PATIENTS WITH COVID-19, AND AS A SUBSTITUTE FOR CURRENT
STANDARD OF CARE IN GENERAL ANESTHESIA FOR WHICH THERE ARE
CURRENTLY SHORTAGES DUE TO CORONAVIRUS PANDEMIC
    * USE IS LIMITED TO PHYSICIANS WHO HAVE EXPERIENCE WITH
REMIMAZOLAM.

Source text for Eikon:  ID:nEQ3F6RN1a 
Further company coverage:  PA8G.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;;))